H3N2 Influenza
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Assess the Safety and Immunogenicity of One or Two Doses of Sing2016 M2SR H3N2 Influenza Vaccine (NCT04960397) | National Institute of Allergy and Infectious Diseases (NIAID) | 2021-09-10 |
Track H3N2 Influenza automatically
Every clearance here is in the API, with alerts when new ones post.